throbber
Cosmetic and Drug
`Preservation
`
`PRINCIPLES AND PRACTICE
`
`Edited by
`JON J. KABARA
`Department of Biomechanics
`Michigan State University
`East Lansing, Michigan
`
`
`
`MARCEL DEKKER, INC.
`
`'
`
`New York and Basel
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 1
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 1
`
`

`

`Library of Congress Cataloging in Publication Data
`Main entry under title:
`
`Cosmetic and drug preservation.
`
`(Cosmetic science and technology ; V. 1)
`Includes index.
`1. Cosmetics--Preservation.
`
`2. Cosmetics--
`
`4. Drugs--
`3. Drugs-—Preservation.
`Microbiology.
`Microbiology. 1. Kabara, Jon J., [date].
`11 . Series.
`TP983.C774 1984
`ISBN 0-8247- 7104-4
`
`84-15603
`
`668'.55
`
`.5)
`6\ i
`fix
`
`COPYRIGHT © 1984 by MARCEL DEKKER, INC.
`
`ALL RIGHTS RESERVED
`
`Neither this book nor any part may be reproduced or transmitted in
`any form or by any means, electronic or mechanical, including photo-
`copying, microfilming, and recording, or by any information storage
`and retrieval system, without permission in writing from the publisher
`
`MARCEL DEKKER, INC.
`270 Madison Avenue, New York, New York 10016
`
`Current printing (last digit):
`10
`9
`8
`7
`6
`5
`4
`3
`2
`1
`
`PRINTED IN THE UNITED STATES OF AMERICA
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 2
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 2
`
`

`

`This material may be protected by Copyright law (Title 17 U.S. Code)
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 3
`
`

`

`54
`
`INTRODUCTION
`
`Haag and Loncrini
`
`The alkyl esters of p-hydroxybenzoic acid, more commonly known in the United
`States as the parabens, are the most widely used preservatives in the cosmetic
`industry today [1] . They were first introduced by Sabalitschka in 1924 [2] ,
`when he presented a series of reports on their use as antimicrobial agents.
`Sabalitschka's primary goal was to find replacements for salicylic and benzoic
`acids, both of which are effective preservatives only in the highly acid pH
`range. His research was rewarding when he found that by esterifying p—
`hydroxybenzoic acid with various alkyl and aryl alcohols, the resulting prod-
`ucts were effective over a wide pH range.
`Official recognition of the parabens came in 1934 with the adoption of the
`methyl ester in the fifth edition of the Swiss Pharmacopeia.
`In the United
`States the methyl ester was first adopted in the National Formulary VII in
`1942; both the methyl and propyl esters were admitted to the U.S. Pharma—
`copeia XIII in 1947. Methylparaben and propylparaben are also contained on
`the "generally recognized as safe" list (Code of Federal Regulations, Title 21
`§184.1490 and 184.1670), with a maximum permissible use quantity of 0.1%.
`In many ways the parabens are ideal cosmetic preservatives. They are
`essentially colorless, odorless, nonvolatile, stable, effective over a wide pH
`range, and relatively active against a broad spectrum of microorganisms.
`Their cost is low in relation to their use concentration. Numerous studies
`
`have indicated that the parabens have a low order of acute and chronic toxic7
`ity [3] , although in some isolated cases contact dermatitis has been reported
`[4] . Therefore, considering the widespread usage of the parabens and the
`low incidence of adverse reactions, it is generally accepted that the parabens
`are among the safest of all cosmetic preservatives.
`
`II. PRODUCTION
`
`The esters of p-hydroxybenzoic acid are prepared by reacting the corre—
`sponding alcohols with p—hydroxybenzoic acid in the presence of an acid cat—
`alyst. The reaction products are formed in high yields, especially if the by-
`product water is removed azeotropically according to the following equation:
`
`CI-OH
`
`IC-OR
`
`ROH
`
`+
`
`H2O
`
`Generally , sulfuric acid or p-toluenesulfonic acid is recommended as the catalyst.
`p—Hydroxybenzoic acid is produced commercially by treating the dry
`potassium salt of phenol with carbon dioxide at temperatures above 200°C
`under 4—7 atm of pressure. The resulting salt is then treated with acid to
`yield p—hydroxybenzoic acid :
`
`co2
`pressure
`
`5
`
`0
`
`KO
`
`0ll
`c-ox
`
`+
`
`on
`
`UCB Biopharma SPRL (IPR2019—00400)
`Exhibit 2027 Page 4
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 4
`
`

`

`
`
`Esters of para—Hydroxybenzoic Acid
`
`65
`
`III. PHYSICAL AND CHEMICAL PROPERTIES
`
`The methyl, ethyl, propyl, and butyl esters of p-hydroxybenzoic acid (shown
`below) are the most widely used by the cosmetic industry [1].
`
`Ou
`C-O-R
`
`OH
`
`Methyl
`Ethyl
`Propyl
`Butyl
`
`R = CH3
`R = 02H5
`R = C3H7
`R = C4H9
`
`These esters may be described as small colorless crystals or as white crystal—
`line powders, slightly to very slightly soluble in water, and soluble to freely
`soluble in nonpolar vehicles. Their water solubility decreases with increasing
`molecular weight, while their lipid solubility increases with increasing mole—
`cular weight (see Table 1). A linear relationship exists between the alkyl
`chain length and the log of the water solubility, and also between chain length
`and the log of the partition coefficient [5] .
`The paraben esters are colorless in solution. The methyl ester has been
`reported to have a slight characteristic odor, whereas the other esters are
`practically odorless in their purified form [5] . No particular taste is notice—
`able in solutions of the esters, but in saturated aqueous solution these esters
`exhibit a slight tang or weak burning sensation in the mouth [5] .
`Both methylparaben and propylparaben undergo acid—catalyzed and
`base—catalyzed ester hydrolysis. Maximum stability for the paraben esters is
`in the pH range of 4—5 [6] . For example, negligible hydrolysis occurred
`after several hours of boiling an aqueous solution of paraben esters at neutral
`or slightly acidic pH levels, while slight hydrolysis occurred after the same
`length of time at pH 8 or above [5] . At higher temperatures and at higher
`pH ranges, hydrolysis occurred rapidly. To exemplify this, Raval and
`Parrott [7] found that after autoclaving (121°C) a methylparaben solution for
`30 min at pH 6 and 9, there remained 94. 5 and 58.0% of the initial paraben con—
`centrations , respectively.
`
`IV. ANTIMICROBIAL ACTIVITY
`
`Table 2 shows the minimal inhibitory concentrations of methyl- , ethyl— , pro—
`py1—, and butylparaben against a variety of molds, yeasts, and bacteria come
`mon in cosmetic spoilage.
`In general, the parabens are more effective
`against yeast and molds than they are against bacteria, and more effective
`against gram—positive bacteria than against gram-negative bacteria. Because
`of their limited water solubility, parabens are not particularly effective
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 5
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 5
`
`

`

` n
`
`mH5no.o3.3.8.9no@852mm«.4Hm.omo«556%mm6«.0m6545.3930
`
`
`
`303mmcwwmmonmx!IadINZNodomvHookfimosoamommM‘modIm.oAcme:
`
`
`
`
`
`
`
`mHodvoéHadmmd00mm
`
`moo.ommoémodwadOomH
`
`demvdwméN.mDoom
`
`ONN«NHmHHmmHofimflaw—Z
`
`OHNmmonan#OQQSH‘W
`
`|fio|mic$38525
`
`|3|2«.93Hoqmfim
`
`a:mmmmmm393mwcwimmofm
`
`
`
`:73mmlwmMilo:Sfilmfi60vESQmass:
`
`
`
`8%395:83593an
`
`#335
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 6
`
`
`
`awnBoa.Hmwaom.80Bog.HmUSOQ
`
`
`
`
`
`66
`
`
`
`23mmEo<ofioNQmthoaukmmumnmm95mommflnmmgmFm_1_m<._.
`
`
`
`
`
`:35m159$TEETEE;3.835
`
`
`
`
`
`MNQE3.2:5.9:3&2Emma.3388:
`
`
`
`SE:SE;SE;SE;8:28AM:
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 6
`
`

`

`67
`
`
`
`Esters of para-Hydroxybenzoic Acid
`
`sopa.33thm
`
`anmpm.3%nonm
`
`:wohgm3%an
`
`omm
`
`mNH
`
`omm
`
`com
`
`0mm
`
`com
`
`mNH
`
`com
`
`omm
`
`com
`
`mg
`
`Nm
`
`mNH
`
`mo
`
`mm
`
`ooOHA
`
`257
`
`com
`
`com
`
`com
`
`com
`
`25
`
`com
`
`omm
`
`com
`
`com
`
`com
`
`0mm
`
`mNH
`
`omm
`
`mNH
`
`mm
`
`25.7
`
`257
`
`O¢OH
`
`oooH
`
`OOOH
`
`coca
`
`com
`
`coca
`
`com
`
`coca
`
`OOOH
`
`ooomA
`
`oooNA
`
`coca
`
`com
`
`com
`
`com
`
`emu
`
`mmH
`
`OOOH
`
`ooov
`
`ooow
`
`OOOH
`
`OOOH
`
`coca
`
`oom
`
`0mm
`
`
`
`
`
`2:vaH3380$935op69$:me:oflmficmonoo
`
`
`
`:wnwhmmrmfiwE
`
`EmEMMpoonoHE
`
`
`
`
`
`
`
`
`
`
`«figs:Enoaoflenfifl$3.3mNmimf.
`
`ooom
`
`ooom
`
`coon
`
`ooom
`
`coca
`
`OOOH
`
`OOOH
`
`coca
`
`ooow
`
`
`
`
`
`mmmfiour:flEEmEQmmzooooszcmsm
`
`
`
`mmmoOOH<35:8mzooooogcnfim
`
`
`
`womwOOH<@322:sz23.6ng
`
`
`
`$8coma89:528:95va
`
`
`
`mamaUOB<MTBPJ>mxmwoci
`
`ampwODH<zooanEmzumm
`
`
`
`
`
`OOHwOCEANWimowwOLdE5:62.me
`
`
`
`
`
`EomOOH<302.533mucoEouzmmm
`
`
`
`
`
`$meOOH<cmoEuszcmczoEovzmmm
`
`
`
`wLmNufiwmwQCOEOanmmA
`
`
`
`mmmmmOOH<@6820ngocngmflcm
`
`
`
`
`
`mew0084mzfinzwmzzwocm
`
`
`
`
`
`82m00:EzcmmewaéoEEEuEwm
`
`
`
`mmHAIQomeEmE:ouzzmoxoth
`
`
`
`$800:.$9:mazmgé
`
`
`
`3.83950mmanEuzoocm
`
`
`
`HmmofiOOH<230.5366.655
`
`
`
`
`
`
`
`
`
`
`
`refiloofiowfisvooNHm8350052:.6983mm.was“mg.mmasflawsKnow33%5MERE;$3CoUEEE.HmmNcamczfim<m
`
`
`
`
`
`
`
`
`
`£3558.meBEDmEEMOwLEoHoo
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 7
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 7
`
`

`

`68
`
`Haag and Loncrini
`
`against Pseudomonas aeruginosa, since more preservative is required for in-
`hibition than would be soluble in water at room temperature.
`The antimicrobial activity of the p-hydroxybenzoic acid esters increases
`with increasing chain length of the alkyl moiety up to and including the butyl
`ester. The benzyl ester has been reported to have even higher activity [8] ,
`but it has not gained widespread acceptance in the cosmetic industry. The
`limitations of use imposed on the longer—chain esters are due to their poor
`aqueous solubilities. Thus, in practice, the lower esters (i.e. , methyl,
`ethyl, propyl, butyl) are most commonly used. The problem of effectiveness
`versus aqueous solubility can be overcome somewhat by combining two or more
`paraben esters in the product formulation. Aalto et a1.
`[5] found that As-
`pergillus niger was inhibited by 0.05% methylparaben or 0.015% propylparaben.
`By combining these two, one can reduce the paraben concentration required
`for complete inhibition of this microorganism to 0.025% methylparaben and
`0.01% propylparaben. This is an additive antimicrobial effect. According to
`Gottfried [9], the main advantage of using paraben mixtures is that the solu—
`bilities of the individual esters are independent of each other. Thus a
`higher total concentration of preservative may be incorporated into the pro—
`duct.
`
`[10] compared the preservative efficacy of methyl- , ethyl—,
`O'Neill et al.
`propyl—, and butylparaben in "problem" products.
`(Problem products were
`defined as products containing high levels of vegetable oils emulsified with
`nonionic surfactants and thickened with weak acid polyelectrolytes at pH
`values above 7.0). Methylparaben was found to be the most effective ester
`in terms of preservative capabilities. The authors did not show any examples
`of better preservation with a mixed paraben system than with an equal weight
`of the methyl ester. Thus they concluded that the least soluble paraben in
`the product is the most efficient in initial potency and capacity. The general
`greater efficacy of methylparaben in such systems was attributed in part to
`its lower solubility in vegetable oils when compared to the longer—chain esters.
`The mechanism of action of the p—hydroxybenzoates corresponds in prin—
`ciple to that of phenol. One proposed mechanism involves the destruction of
`the cell membrane and protein denaturation in the interior of the cell. An-
`other involves competitive reactions with coenzymes [11] .
`..
`Development of resistance was shown not to occur by Luck and Rickerl
`(Resistance is defined here as an increase in the minimum inhibitory
`[12] .
`concentrations under the influence of subthreshold concentrations of p—
`hydroxybenzoic acid esters.) However, more recent work by Peterson et al.
`[13] indicated that Escherichia coli has the ability to adapt to paraben solu—
`tions. Similarly O'Neill and Mead [14] stated that the rate of adaptation in—
`creased markedly with increasing molecular weight; E. coli adapted readily
`to propylparaben and hardly at all to the methyl analog. As a result, O'Neill
`ranked the parabens in the order methyl > ethyl > propyl > butyl > benzyl in
`their antimicrobial capacities.
`Various agents have been reported to potentiate the antimicrobial activity
`of the parabens. Prickett et a1.
`[15] demonstrated that 2—5% propylene glycol
`enhanced the antimicrobial activity of the parabens against vegetative cells,
`but not against bacterial spores. Phenylethanol was reported by Richards and
`McBride [16] to enhance paraben antimicrobial activity in ophthalmic prepara—
`tions. Similarly, ethylenediaminetetraacetate (EDTA) increased the activity
`of the p-hydroxybenzoic acid esters against gram—negative organisms, espec-
`ially P. aeruginosa [17] .
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 8
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 8
`
`

`

`Esters of para-Hydroxybenzoic Acid
`
`69
`
`V. FACTORS INFLUENCING ANTIMICROBIAL ACTIVITY
`
`The antimicrobial action of the parabens is inactivated by several known
`mechanisms. The more notable ones that can significantly influence activity
`are the type and concentration of surfactant, the oil—to—water ratio, pH, and
`the presence of certain macromolecules or other potentially binding solids.
`
`A . Surfactants
`
`Paraben inactivation by nonionic surfactants has been well known for several
`decades. Their inactivating effects are of greater significance than those of
`anionic and cationic systems because nonionic surfactants have no growth—
`inhibiting properties. Thus the necessity for adequate preservation of sys-
`tems containing them is much greater.
`Belle and Mirimanoff [18] were the first to emphasize the reduced effect
`of methylparaben in the presence of several structurally different nonionic
`surfactants. Their findings stimulated a widespread interest in the pharma-
`ceutical and cosmetic industries.
`Investigations by de Navarre [19] and
`deNavarre and Bailey [20] led to the conclusion that any soluble ethoxylated
`nonionic surfactant would inactivate the paraben esters at use concentrations in
`an agar medium -, For example, deNavarre found that O. 1% paraben was ineffective
`in the presence of 1% nonionic surfactant. Similar studies by Blaug and Ahsan
`[21] dealing with the interaction of the methyl, ethyl, propyl, and butyl
`esters with several nonionic macromolecules indicated that the higher mole-
`cular weight esters were inactivated to a greater extent than those of lower
`molecular weight. Other studies and reviews in the literature have confirmed
`the ability of nonionic surfactants to reduce paraben activity [22—25] .
`The mechanism of paraben inactivation by nonionic surfactants has also
`received considerable study. Aoki et a1. [26] attributed the decrease of
`paraben activity to the envelopment of the paraben in a micelle formed by the
`nonionic surfactant. Evans [27] explained inactivation on the basis of solu—
`bilization of the preservative in the nonionic micelles. Thus compounds with
`high micellar solubility would be present in insufficient quantities in the
`aqueous phase to inhibit microbial growth.
`Patel and Kostenbauder [28] employed a semipermeable membrane to
`evaluate the degree of binding or intermolecular association between paraben
`esters and Tween 80. Both the methyl and propyl esters were investigated,
`and a relatively high degree of interaction with Tween 80 was observed for
`both. These authors concluded that the binding was a function of both the
`concentration of unbound p—hydroxybenzoate and the concentration of Tween
`80. Patel and Kostenbauder also noted that the propyl ester had a far greater
`affinity for Tween 80 than the methyl ester. At a concentration of 5% Tween
`80, 22% of the total methylparaben existed as a free preservative, whereas in
`the case of the propyl ester, only 4. 5% existed as free propylparaben.
`paraben.
`Later studies by Pisano and Kostenbauder [29] demonstrated that the
`activity of p—hydroxybenzoates in the presence of nonionic surfactants is a
`function of the unbound preservative. They suggested that the total con-
`centration of preservative required to protect a nonionic formulation could
`be estimated from predetermined binding data. These investigations suggest
`that the required concentration of p—hydroxybenzoates can be estimated by
`multiplying the preservative use level by the ratio of total to free preservative
`at any given Tween 80 concentration. This approach to emulsion preservation
`assumes, however, that other factors such as the oil—water ratio or pH do
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 9
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 9
`
`

`

`70
`
`Haag and Loncrini
`
`not contribute to the efficacy of the preservative. Since it is known that
`these factors can exert powerful influences, it would be wrong to rely on this
`kind of prediction to the exclusion of other considerations.
`While most nonionic inactivation studies were conducted in relatively sim—
`ple aqueous systems, Charles and Carter [30] determined the activity of p—
`hydroxybenzoates in 18 typical nonionic cosmetic emulsions. They found the
`preservatives to be more effective in these products than would be antici—
`pated from results obtained with simpler systems. Their results indicated
`the need for testing the final finished product with all components present.
`Propylene glycol has been shown to potentiate the activity of the p-hy—
`droxybenzoates in the presence of nonionic surfactants. According to Poprzan
`and deNavarre [31] , 10% propylene glycol prevented the interaction between
`methylparaben and Tween 80.
`
`B . Partition Coefficients
`
`Owing to their high oil solubility, p—hydroxybenzoates have relatively unfav-
`orable partition coefficients between the oil and water phases of emulsions.
`Protection of these emulsions requires that lethal levels of the preservative
`contact the microorganisms in the aqueous phase.
`In an emulsion containing
`50% or more oil, more preservative may be present in the oil phase than in the
`aqueous phase after equilibrium is achieved. Thus a considerable proportion
`of the preservative can become inactivated by migration into the wrong
`phase. This migration can occur over a considerable period of time, which is
`one more reason why prolonged microbiological testing of formulated products
`is required.
`Hibbot and Monks [32] determined the oil—water partition coefficient of
`methylparaben in a number of oils and waxes. They then tested the activity
`of this preservative in a series of creams prepared from these oils and waxes
`covering a range of calculated partition coefficients. Results of their tests
`showed good correlation between activity and partition coefficients, indicating
`that this property can be used to estimate the performance of a preservative
`in an emulsion.
`
`[33] determined the parition coefficients of methylparaben
`Bean et al.
`in aqueous mixtures and emulsions of mineral oil, safflower oil, isopropyl pal-
`mitate, and lanolin. The oil—water coefficient for the preservative in mineral
`oil was 0.11 because of its limited solubility in this vehicle. The partition co—
`efficients in the other oils, on the other hand, were about 100—150 times
`greater than in mineral oil.
`
`The partition coefficient of many preservatives can be reduced by the
`addition to the aqueous phase of a substance in which the preservative is
`preferentially soluble. Propylene glycol, glycerin, sorbitol, and hexylene
`glycol are examples which can have advantageous effects in certain systems
`[34] . Humectants can, of course, provide an added benefit by increasing
`the osmotic pressure of the aqueous phase and thus increasing the inhibitory
`effect of the preservative. Propylene glycol, in addition, appears to have
`toxic effects on bacteria and fungi in its own right if used in the aqueous
`phase at a concentration of 15%.
`
`C.
`
`pH
`
`The parabens are effective over a pH range of 4—8. As the pH rises above 8,
`the parabens become less effective because of disassociation of the molecule.
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 10
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 10
`
`

`

`Esters of para—Hydroxybenzoic Acid
`
`71
`
`.
`
`At a pH of 8.5, 50% of the compound is disassociated, and considerable loss
`of antimicrobial activity occurs. At pH 7 the parabens are 60— 65% effective
`[35] .
`
`D. Other lnactivating Agents
`
`Binding of parabens by other macromolecular materials has been reported.
`Interaction between methyl cellulose and the parabens was reported by Till—
`man and Kuramoto [36] . The methyl p—hydroxybenzoate showed the greatest
`binding effect, while the butyl ester showed the least. According to Miya—
`waki et a1. [37], methyl— and propylparaben are bound to some extent with
`polyethylene glycol, polyvinylpyrrolidone, and gelatin. No significant inter-
`action was noted with carboxymethylcellulose or tragacanth. These authors
`concluded that the concentrations of macromolecular polymers commonly used
`were not sufficient to interfere seriously with the use of the parabens.
`
`VI. APPLICATIONS
`
`The paraben esters are commonly used at levels of 0.1—0.8% in cosmetic pro—
`ducts. Combinations of these esters are generally found to be more effective
`against bacteria, yeasts, and molds than single esters. These combinations
`take advantage of the fact that each ester is independently soluble, and as a
`result, a higher combined concentration can effectively be introduced into a
`formulation.
`
`In many cosmetic formulations the paraben esters are used in combination
`with other preservations. Advantages of using preservative combinations
`include the following aspects:
`(1) The spectrum of activity can be increased,
`(2) the toxicological hazard can be reduced by using lower concentrations of
`component preservatives, (3) the development of resistance by an organism
`to one preservative alone may be prevented, and (4) additive or synergistic
`activities may result. The combination of Germall 115 (Sutton Laboratories,
`Inc.) and the paraben esters has been recommended [38] . Mixtures of the
`paraben esters with Glydant (Glyco Chemicals, Inc.) , Bronopol (The Boots
`Co. , Ltd.), and Dowicil 200 (Dow Chemical Co.) , among others, are also
`common throughout the cosmetic industry.
`
`VII. METHODS OF INCORPORATION
`
`The incorporation of the p—hydroxybenzoic acid esters into various formula—
`tions requires a familiarity with their solubility characteristics, particularly
`in water. Even though their water solubility is limited, they can be dis—
`solved in aqueous products at room temperature, provided that good agitation
`is maintained. The rate of solution is a function of particle size. With the
`fine powders that are normally available, aqueous concentrations of 0.20%
`methyl, 0.10% ethyl, 0.03% propyl, or 0.015% butyl can be achieved in 20 or
`30 min. A coarse powder, on the other hand, dissolves only after a long
`period of continuous stirring. Dissolution can be accomplished more readily
`by heating the medium to 70 or 75°C and stirring until solution is complete.
`This temperature should be kept about 20°C below the melting point of the
`paraben ester used to prevent agglomeration of the paraben particles.
`Another method of incorporation involves the preparation of stock solu-
`tions of the paraben esters in solvents such as alcohol or propylene glycol.
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 11
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 11
`
`

`

`72
`
`Haag and Loncrini
`
`Such a solution must be added slowly to the aqueous phase of the formulation
`in order to prevent precipitation of the ester.
`
`Vlll. TOXICITY
`
`A. Acute Toxicity
`
`Sokol [3] reported the acute oral LD50 in mice to be greater than 8 g/kg of
`body weight for the methyl, ethyl, and propyl esters, and greater than 5
`g/kg for the butyl ester.
`In a similar study, Matthews and co-workers [39]
`determined the LD50 in mice of orally administered methylparaben to be 8
`g/kg of body weight, and the intraperitoneal LD50 to be 960 mg/kg of body
`weight. These authors observed the acute toxicity to increase with an in-
`crease in the molecular weight of the ester, and they judged the butyl ester
`to be approximately three times as toxic as the methyl ester. Symptoms of
`acute toxicity observed include ataxia, paralysis, hypotension, and general
`and myocardial depression. The animals that survived the test, however,
`recovered rapidly.
`
`B . Subchronic Toxicity
`
`[39] reported that dogs fed 500 and 1000 mg/kg methylparaben
`Matthews et a1.
`per day were unaffected after 1 year on the regimen. Sabalitschka and
`Neufeld—Crzellitzer [40] reported that a man was unaffected after taking
`2000 mg of methylparaben daily for 1 month. Similar studies by Braccesi [41]
`confirmed these observations.
`
`C . Chronic Toxicity
`
`Weanling Wistar rats, fed 0.9—1.2 g/kg of either methyl- or propylparaben
`for 96 weeks remained indistinguishable from the controls. Autopsies revealed
`no pathological changes in kidney, liver, heart, lung, spleen, or pancreas.
`When the dosage of either compound was increased to approximately four
`times these amounts, rats showed a slower rate of weight gain than the con—
`trols. These authors estimated that the toxic threshold for rats of both
`
`methyl— and propylparaben is at least 3000 mg/kg per day [39] .
`Sokol [3] reported that propylparaben stimulated growth in rats when fed
`at a dosage of 150 mg/kg per day for 18 months. On the other hand a dosage
`of 1500 mg/kg per day for the same period resulted in a growth depression
`without specific pathology.
`A survey by the U.S. Department of Commerce [42] revealed that there
`are no short—term toxicological consequences in the rat, rabbit, cat, dog, or
`man, and no long-term toxicological consequences in rats when the parabens
`are consumed in amounts greatly exceeding those currently consumed in the
`normal diet of the U.S. population.
`
`D. Biochemical Behavior
`
`p-Hydroxybenzoic acid esters are readily and completely absorbed from the
`gastrointestinal tract.
`In a study by Matthews et al.
`[39] in which dogs
`were orally administered 1.0 g of methyl— or propylparaben per kilogram
`body weight per day for 1 year, between 96 and 100% of the daily administered
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 12
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 12
`
`

`

`Esters of para—Hydroxybenzoic Acid
`
`73
`
`[43]
`In a similar study Jones et a1.
`dose was accounted for in the urine.
`found no accumulation of methyl- or propylparaben or their metabolites in dogs
`which had been given 1.0 g/kg per day for 1 year. These authors were able
`to account for 96% of the daily administered dose in the urine in the form of
`free or conjugated p—hydroxybenzoic acid. By giving a fasted man 70 mg of
`methylparaben per kilogram body weight, they concluded that the paraben is
`handled similarly in human metabolism .
`
`E . Carcinogenicity
`
`A carcinogenic study reported by Homberger [44] which involved several
`techniques for ascertaining carcinogenicity, that is, subcutaneous injection—
`secondary host transfer, intravenous injection—observation of lung adenomas,
`and cocarcinogenesis, showed that methylparaben did not have carcinogenic
`activity. Boyland et a1.
`[45] dissolved methylparaben in polyethylene glycol
`and, by introducing it twice weekly into the vaginas of weanling mice for 18
`months, found no initiation of carcinomas.
`
`F. Teratogenicity
`
`Methylparaben elicited no teratogenic response in pregnant mice or rats when
`these were fed up to 550 mg/kg per day for 10 consecutive days, or in preg—
`nant hamsters when these were fed up to 300 mg/kg per day for 5 consecutive
`days [46] .
`
`G. Skin Irritation Studies
`
`[39] reported Shelanski‘s [47] results on human patch tests
`Matthews et a1.
`carried out with the paraben esters. The esters were dissolved in propylene
`glycol at 5, 7, 10, 12, and 15%. The highest percentages not causing irrita-
`tion were methyl, 5%; ethyl, 7%; propyl, 12%; and butyl, 5%. Repeated insult
`tests were also carried out on 50 subjects and no sensitization was observed.
`The parabens, when used in topical therapeutic agents, have been reported
`to sensitize approximately 1% of the population with eczematous dermatitis [4] .
`However, these identical parabens are generally considered "safe" in cosmetic
`preparations widely used by thousands of persons. The reason for this is
`that cosmetics are usually applied to normal skin, whereas therapeutic agents
`are applied to inflamed, eczematous, excoriated, or otherwise damaged skin,
`which is much more readily sensitized than even the thinnest normal skin.
`Simpson [48] reported a rare instance of a patient with allergic hypersen—
`sitivity to parabens in several cosmetic preparations. Similarly, Henry et a1.
`[49] reported a case of contact urticaria developed in a patient after topical
`application of several paraben—containing compounds. While occasional cases
`of paraben sensitivity occur, the incidence of sensitization is low when the
`extensive use of the material is considered.
`
`H. Eye Irritation Studies
`
`Methyl- and propylparaben as saturated aqueous solutions have been reported
`to be moderately irritating to the eye [50]. According to Foster [51] , nearly
`saturated solutions of parabens are too irritating to the eyes for inclusion in
`ophthalmic preparations .
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 13
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 13
`
`

`

`74
`
`IX . COMMERCIAL PRODUCTS
`
`Haag and Loncrini
`
`The methyl, ethyl, propyl, and butyl esters of p—hydroxybenzoic acid are
`generally sold directly by domestic producers, although some imported material
`is handled through distributors and agents. Blends of the methyl and propyl
`esters are also available to the industry.
`A liquid paraben is now commercially available to the cosmetic and toiletry
`industry. LiquaPar (Mallinckrodt, Inc.) , a 50% by weight paraben oil-in-
`water emulsion, consists of 20% isopropyl-p-hydroxybenzoic acid, 15% iso-
`butyl-p—hydroxybenzoic acid, and 15% n-butyl—p—hydroxybenzoic acid. The
`remaining 50% is water containing emulsion stabilizers. The principle behind
`the product is that the three solid paraben esters, when combined in the proper
`ratio, form a eutectic oil which has a freezing point near 0°C. This oil can
`then be easily emulsified.
`
`According to the manufacturer, LiquaPar offers the following advantages
`over conventional crystalline paraben esters:
`ease of incorporation into
`formulations, since additional solvents are not necessary; a decreased chance
`of error in formulation measurements; elimination of paraben particle size
`problems, thus eliminating the chance of grittiness in creams or lotions; sub—
`stantial savings in labor and product preparation time; and cost effectiveness
`in many formulations.
`
`X. METHODS OF DETECTION AND DETERMINATION
`
`The literature contains a number of papers on the detection and determina-
`tion of the pihydroxybenzoates in various formulations. A colorimetric
`method, described by Jones et a1.
`[43] , makes use of the reagent 4—aminoanti—
`pyrine. Higuchi and co-workers [52] described a method based on prelimin-
`ary extraction of the paraben from the product, separation of the component
`esters by partition chromatography, and subsequent determination of the in—
`dividual constituents by ultraviolet spectrophotometry.
`Liem [53] described a quantitative determination of the paraben esters
`using gas—liquid chromatography.
`In this procedure, the parabens are ex—
`tracted from the product with methanol, purified by thin—layer chromatography,
`and derivatized with N,O—bis-trimethy1-silyl acetamide prior to injection.
`The concentrations of the esters are calculated from a standard calibration
`curve.
`
`Methods of detection and determination have also been developed using
`high—performance liquid chromatography [54] .
`
`REFERENCES
`
`1. E. Richardson. Update-frequency of preservative use in cosmetic
`formulas as disclosed to FDA, Cosmet. Toiletr. , 96:91— 92 (1981).
`2. T. Sabalitschka. Chemische Konstitution und Conservierungsvermogen,
`Chem. Ztg., 48:703 (1924).
`3. H. Sokol. Recent developments in the preservation of pharmaceuticals,
`Drug Stand., 20:89—106 (1952).
`4. A. Fisher. Cosmetic dermatitis part 11, reactions to some commonly
`used preservatives, Curr. Contact News, 26:136—148 (1980).
`5. T. Aalto, M. Firman, and N. Rigler.
`p-Hydroxybenzoic acid esters
`as preservatives I, J. Am. Pharm. Assoc. Sci. Ed., 42:449—457 (1953).
`6. K. Connors, G. Amidon, and L. Kennon. Chemical Stability of Phar—
`maceuticals, Wiley, New York, (1979), pp. 260—265, 307—310.
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 14
`
`UCB Biopharma SPRL (IPR2019-00400)
`Exhibit 2027 Page 14
`
`

`

`Esters of para—Hydroxybenzoic Acid
`
`75
`
`from art to
`
`N. Raval and E. Parrott. Hydrolysis of methylparaben, J. Pharm.
`Sci., 56:274—275 (1967).
`E. MacDonald. The preservative p—hydroxybenzoic acid esters, J.
`Am. Pharm. Assoc. Prac. Pharm. Ed., 3:181 (1942).
`N. Gottfried. Alkyl p—hydroxybenzoate esters as pharmaceutical pre-
`servatives. A review of the parabens, Am. J. Hosp. Pharm., 19:310—
`314 (1962).
`J. O'Neill, P. Peelor, A. Peterson, and C. Strube. Selection of para—
`bens as preservatives for cosmetics and toi

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket